Arne M. Nystuen;Vincent Ling;Paul Stabila;Konrad Kauper;Weng Tao
发明人:
Vincent Ling,Arne M. Nystuen,Weng Tao,Paul Stabila,Konrad Kauper
申请号：
US13308264
公开号：
US09149427B2
申请日:
2011.11.30
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention provides nucleic acid and polypeptide sequences encoding antibody based scaffolds such as full antibodies, antibody Fab fragments, single chain antibodies, soluble VEGF receptor-Fc fusion proteins, and/or anti-angiogenic PDGF receptors. Also encompassed are cell lines encoding such anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors. The invention also provides encapsulated cell therapy devices that are capable of delivering such anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors as well as methods of using these devices to deliver the anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors to medically treat disorders in patients, including ophthalmic, vascular, inflammatory, and cell proliferation diseases.
